Elanco Animal Health Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
United States of America US
Employees
9 650
IPO date
Sep 20, 2018

Elanco Animal Health makes medicines and health products for animals. It sells prescription drugs, vaccines, and parasite control products for pets and farm animals. The company’s main customers are veterinarians, pet owners, livestock producers, and animal health distributors that buy its products and pass them on to end users.

Elanco earns money by selling these animal care products through clinics, retailers, distributors, and agricultural channels. Its business is tied to the ongoing need to prevent disease, treat illness, and support animal health rather than one-time purchases of equipment or services. That gives it a recurring, product-based revenue model that depends on pets needing routine care and farms needing healthier animals.

What makes Elanco’s role distinct is that it sits between drug research and day-to-day animal care. It develops and markets treatments that help keep companion animals healthy and livestock productive, so it serves both the pet market and the food-animal supply chain. This puts the company in a specialized corner of healthcare where demand is driven by veterinary practice, animal ownership, and the economics of farming.

Elanco Animal Health Inc Investor Relations

Address
450 Elanco Circle
Indianapolis, Indiana
United States of America

Business Segments

Pet Health

This business sells medicines and other health products for dogs and cats, including treatments for fleas, ticks, worms, and other common conditions.

Customers and revenue model

Farm Animal

This business sells health products for livestock such as cattle, pigs, and poultry, including medicines that help treat disease and support animal care on farms.

Customers and revenue model

Management

Mr. Jeffrey N. Simmons

President, CEO & Director

Biography unavailable

Mr. Todd S. Young J.D.

Executive VP & CFO

Biography unavailable

Dr. Ramiro Martin Cabral

Executive Vice President of Elanco International

Biography unavailable

Dr. Ellen de Brabander Ph.D.

Executive Vice President of Research, Development & Regulatory Affairs

Biography unavailable

Mr. Timothy J. Bettington

Executive Vice President of Corporate Strategy & Market Development

Biography unavailable

Mr. James M. Meer

Senior VP & Chief Accounting Officer

Biography unavailable

Mr. Chris Keeley

Senior VP & Chief Information Officer

Biography unavailable

Mr. David S. Kinard

Executive Vice President of Human Resources, Corporate Communications & Administration

Biography unavailable

Ms. Katy Grissom

Head of Investor Relations

Biography unavailable

Ms. Shiv O'Neill

Executive Vice President, General Counsel & Corporate Secretary

Biography unavailable

1 / 10